OnKure Therapeutics (OKUR) Shares Issued (2020 - 2026)
OnKure Therapeutics' (OKUR) quarterly Shares Issued came in at $2.7 million in Q1 2026, down 11.56% YoY from $3.0 million in Q1 2025, and down 0.78% on a QoQ basis from $2.7 million in Q4 2025.
OnKure Therapeutics (OKUR) Shares Issued (2020 - 2026) Analysis & Trends
OnKure Therapeutics (OKUR) has 7 years of Shares Issued data on file, last reported at $2.7 million in Q1 2026.
- Quarterly Shares Issued fell 11.56% year-over-year to $2.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.7 million (down 11.56% YoY) and the FY2025 annual result came in at $2.7 million, up 13.4% from the prior year.
- Shares Issued eased to $2.7 million in Q1 2026, from $2.7 million in the prior quarter.
- In the past five years, Shares Issued ranged from a high of $6.1 million in Q3 2023 to a low of $178232.0 in Q4 2023.
- A 5-year average of $3.4 million and a median of $3.1 million in 2025 frame the typical range for Shares Issued.
- Annual changes were most pronounced in 2023 — Shares Issued tumbled 96.97% — and 2024, when it soared 1243.09%.
- Tracing OKUR's Shares Issued over 5 years: stood at $5.9 million in 2022, then plunged by 96.97% to $178232.0 in 2023, then soared by 1243.09% to $2.4 million in 2024, then grew by 13.4% to $2.7 million in 2025, then fell by 0.78% to $2.7 million in 2026.
- The last three Shares Issued figures came in at $2.7 million (Q1 2026), $2.7 million (Q4 2025), and $839941.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | - |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | OnKure Therapeutics | 196.98 Mn | 20.60 Mn | - | 4.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.08 Mn |
| Jun 30, 2026 | 4.08 Mn |
| Mar 31, 2026 | 2.69 Mn |
| Mar 31, 2026 | 2.69 Mn |
| Dec 31, 2025 | 2.71 Mn |
| Dec 31, 2025 | 2.71 Mn |
| Sep 30, 2025 | 839,941.00 |
| Sep 30, 2025 | 839,941.00 |
| Jun 30, 2025 | 3.05 Mn |
| Jun 30, 2025 | 3.05 Mn |
| Mar 31, 2025 | 3.05 Mn |
| Mar 31, 2025 | 3.05 Mn |
| Dec 31, 2024 | 2.39 Mn |
| Dec 31, 2024 | 2.39 Mn |
| Sep 30, 2024 | 467,129.00 |
| Sep 30, 2024 | 467,129.00 |
| Jun 30, 2024 | 3.52 Mn |
| Jun 30, 2024 | 3.52 Mn |
| Mar 31, 2024 | 3.37 Mn |
| Mar 31, 2024 | 3.37 Mn |